Chapter 10: Antepartum Fetal Assessment Flashcards
1
Q
why is an antepartum fetal assessment done?
A
- to detect congenital anomalies and evaluate the condition of the fetus
- but no antepartal testing or antepartal surveillance procedure can guarantee the birth of a perfect infant
2
Q
role of perinatal nurses in antepartal fetal assessments
A
- be prepared to offer clear explanations of diagnostic procedures and any problems the woman should report
- support for the family requiring fetal diagnostic tests can reduce their anxiety
3
Q
antepartum fetal assessment
A
- Each is an assessment to measure the presence or absence of fetal well being
- Potentially only for indications
- Some are within the scope of nursing practice to do
- Some are not, but a nurse is expected to participate in procedure and/or provide patient education
4
Q
goals of antepartum fetal assessment
A
- determine fetal health or compromise accurately
- reduce perinatal morbidity and mortality
- guide intervention by the OB team
5
Q
ultrasound
A
- can provide 2D or 3D imaging
- real time so able to observe fetal heart motion, fetal breathing, fetal movement
- can be done transabdominally or transvaginally
6
Q
levels of ultrasound
A
- standard (basic): general survey of fetus, placenta, and amniotic fluid volume
- specialized (comprehensive): done if abnormalities found during basic scan
- limited: done to address placental location, fetal cardiac activity, determine presentation, assess volume of amniotic fluid
7
Q
first trimester ultrasonography
A
- most used to:
- confirm pregnancy
- verify location of pregnancy and identify multifetal gestation
- determine gestation age
- determine location of uterus, cervix, placenta for chorionic villus sampling (CVS)
- crown rump (CRL) measurement is most reliable measurement of gestational age
- viability confirmed by fetal heartbeat which is visible when CRL is 5 mm
8
Q
second and third trimester ultrasonography
A
- usually transabdominal
- purposes:
- confirm viability
- evaluate anatomy
- confirm gestational age
- assess fetal growth
- locate placenta
- determine preseantation
- becomes more difficult to evaluate gestational age, but need accurate fetal age if assessing alpha getoprotein levels or looking at IUGR
9
Q
advantages of ultrasound
A
- shows clear visibility of the fetus and surrounding structures
- has been proven safe
- noninvasive
- comfortable
- results are immediate
- portable and available
10
Q
disadvantages of ultrasound
A
- cost
- if don’t get an ultrasound during 1st trimester, gestational age will not be calculated as accurately
- cannot identify all defects of fetal structure or function
- possible anxiety for new parents if abnormal results are found
11
Q
dopper ultrasound
A
- used when pregnancies are complicated by HTN or fetal growth restriction to identify abnormalities in blood flow
12
Q
alpha fetoprotein screening
A
- AFP is the predominant protein in the fetal plasma
- it diffuses from fetal plasma to fetal urine to the amniotic fluid
- some crosses the placenta, so it can be measured in maternal blood (MSAFP) or in amniotic fluid (AFAFP)
- low levels of MSAFP suggest chromosomal abnormalities, like trisomy 21
- elevated levels of MSAFP suggest neural tube defects like anencephaly or spina bifida
- done b/w 16 and 18 weeks gestation
- can be affected by gestational age, maternal weight, multifetal pregnancy, race, maternal diabetes, and ethnicity
13
Q
advantages of MSAFP evaluation
A
- simple
- not invasive to fetus
- economic
- early screening so allows time for more comprehensive screening if it comes back abnormal
14
Q
limitations of MSAFP evaluation
A
- screening test, not diagnostic
- benign conditions such as inaccurate estimation of gestational age can result in apparently abnormal levels in a health fetus
- timing: can only be done b/w 16-18 weeks
- normal levels of AFP do not guarantee that the baby is free of structural defects
15
Q
multiple marker screening
A
- test for hCG and unconjugated estriol (along with MSAFP): triple screen
- inc detection of trisomy 18 and 21, so noninvasive test for NTD
- samples taken b/w 16-18 weeks, and are considered positive for an anomaly if MSAFP and estriol are low and hCG is high
- quad screen: adds placental inhibin A which will help improve screening of trisomy 21 in women under 35